Exchange: NYSE·Updated 03:24 PM EDT
News
all
press releases
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis
Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis PR Newswire ABBOTT PARK, Ill. and ROSEMONT, Ill., Aug. 12, 2026 "We Give Blood" brings together all 18 Big Tenschoolsin a competition to...
PR Newswire
More News
Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI
Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI Abbott and Google launch first-of-its-kind partnership to transform everyday health through glucose insights and AI PR Newswire ABBOTT PARK, Ill., Aug. 11, 2026 Multi-year...
PR Newswire
Should You Buy, Hold or Sell ABT Stock Amid Medical Devices Boom?
Abbott's Medical Devices growth, EPD momentum and improving Nutrition support its outlook, but China risks, costs and valuation warrant caution.
Zacks
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbVie relies on a high-margin biopharmaceutical portfolio and significant free cash flow to drive shareholder value...
Nasdaq News: Markets
NVST vs. ABT: Which Stock Is the Better Value Option?
NVST vs. ABT: Which Stock Is the Better Value Option?
Zacks
Here's How ABT Broadens Diagnostics Growth Base With Oncology Expansion
Abbott broadens Diagnostics growth with Exact Sciences, as Cancer Diagnostics gains and resilient routine testing offset respiratory weakness.
Zacks
Boston Scientific's 2026 Guidance Cut Puts Its Recovery to the Test
Boston Scientific's 2026 guidance cut tests its recovery as WATCHMAN weakness, EP share losses and delayed margin gains push a broader rebound toward 2028.
Zacks
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbott Laboratories maintains a diversified business model spanning diagnostics, medical devices, and nutrition products...
Nasdaq News: Markets
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
Key PointsAbbott Laboratories leverages a diversified portfolio across medical devices and diagnostics, bolstered by its recent acquisition of Exact Sciences...
Nasdaq News: Markets
These 3 Companies Reported Record Results and Raised Guidance
Abbott Laboratories, Taiwan Semiconductor, and Johnson & Johnson have all delivered strong earnings releases in the Q2 cycle, with each breaking records while also lifting their outlooks.
Zacks

Advertisement|Remove ads.